June 10, 2022
Adjunctive metformin in bipolar disorder. Researchers performed a randomized clinical trial of treating insulin resistance to improve clinical outcomes in treatment-resistant bipolar depression.
June 02, 2022
Zuranolone, an investigational oral drug being evaluated in women with postpartum depression, sees positive phase 3 study results.
May 19, 2022
Axsome Therapeutics announced the robust antidepressant efficacy demonstrated in this latest study.
May 18, 2022
Here’s why we should be paying special attention to women's depression treatment.
May 10, 2022
Recommendations are often vague, contradictory, according to investigators.
May 09, 2022
Home environments have a clear impact on depression treatment outcomes.
May 06, 2022
In this CME, review novel, currently available, and promising pharmacological treatment options for treatment-resistant depression.
May 02, 2022
Zuranolone, a drug for the treatment of major depressive disorder and postpartum disorder, is on a rolling submission of a new drug application.
April 29, 2022
The experts weighed in on a wide variety of psychiatric issues for the April 2022 issue of Psychiatric Times.
April 25, 2022
The most common issues during the COVID-19 pandemic included stress, anxiety.